In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
Lingxiao Chen,1,* Wei He,1,* Huichuan Jiang,1,* Longxiang Wu,1 Wei Xiong,1 Bolun Li,1 Zhihua Zhou,2 Yuna Qian3–5 1Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; 2School of Chemistry and Chemical Engineering, Hunan University of Science an...
Guardado en:
Autores principales: | Chen L, He W, Jiang H, Wu L, Xiong W, Li B, Zhou Z, Qian Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bed1764e07ca4ab6a5651dc72c9b2962 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PSMA-Targeting Reduction-Cleavable Hyperbranched Polyamide-Amine Gene Delivery System to Treat the Bone Metastases of Prostate Cancer
por: Ye Y, et al.
Publicado: (2020) -
Application of Machine Learning Techniques to Predict Bone Metastasis in Patients with Prostate Cancer
por: Liu WC, et al.
Publicado: (2021) -
The Potential Use of Aptamers in The Process of Drug Development
por: Tooba Gholikhani, et al.
Publicado: (2021) -
First report of in vitro selection of RNA aptamers targeted to recombinant Loxosceles laeta spider toxins
por: Sapag,Amalia, et al.
Publicado: (2014) -
Novel Aptamer-Functionalized Nanoparticles Enhances Bone Defect Repair By Improving Stem Cell Recruitment
por: Wang M, et al.
Publicado: (2019)